Skip to main content

ADVERTISEMENT

T Joseph Mattingly II, PhD, PharmD, MBA

We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
02/22/2021
Jason Shafrin, PhD
Marlon Graf, PhD
Rifat Tuly, MPH
Christoph Glaetzer, Dipl Kfm
Stacey Hickson, PhD
T Joseph Mattingly II, PhD, PharmD, MBA
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
...
02/22/2021
Journal of Clinical Pathways